Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | 1.08 | 1.92 | 4.19 | 6.03 |
| Cost Of Revenue | 0.01 | 0 | 0 | 0 |
| Gross Profit | 1.08 | 1.92 | 0 | 0 |
| Operating Expense | 49.03 | 56.77 | 56.66 | 55.06 |
| Operating Income | -47.95 | -54.85 | -52.47 | -49.03 |
| EBITDA | -46.50 | -53.43 | -51.62 | -48.48 |
| EBIT | -47.95 | -54.85 | -52.47 | -49.03 |
| Pretax Income | -36.54 | -15.05 | -7.51 | -9.48 |
| Tax Provision | 0.98 | 1.26 | 1.61 | 1.89 |
| Net Income | -37.52 | -16.32 | -9.13 | -11.37 |
| Net Income Common Stockholders | -37.52 | -16.32 | -9.13 | -11.37 |
| Total Expenses | 49.03 | 56.77 | 56.66 | 55.06 |
| Interest Income | 0.06 | 1.14 | 2.37 | 2.16 |
| Research And Development | 3.59 | 4.44 | 5.70 | 5.74 |
| Selling General And Administration | 43.99 | 50.91 | 50.12 | 48.78 |
| Normalized EBITDA | -57.60 | -91.82 | -93.97 | -85.80 |
| Normalized Income | -46.29 | -46.64 | -42.58 | -40.85 |
| Basic EPS | -2.07 | -0.87 | -0.49 | -0.61 |
| Diluted EPS | -2.07 | -0.87 | -0.49 | -0.61 |
| Tax Effect Of Unusual Items | 2.33 | 8.06 | 8.89 | 7.84 |
| Tax Rate For Calcs | 0.21 | 0.21 | 0.21 | 0.21 |
| Total Unusual Items | 11.10 | 38.39 | 42.34 | 37.32 |
| Total Unusual Items Excluding Goodwill | 11.10 | 38.39 | 42.34 | 37.32 |
| Net Income From Continuing Operation Net Minority Interest | -37.52 | -16.32 | -9.13 | -11.37 |
| Reconciled Depreciation | 1.45 | 1.42 | 0.84 | 0.55 |
| Reconciled Cost Of Revenue | 0.01 | 0 | 0 | 0 |
| Net Interest Income | 0.06 | 1.14 | 2.37 | 2.16 |
| Net Income From Continuing And Discontinued Operation | -37.52 | -16.32 | -9.13 | -11.37 |
| Total Operating Income As Reported | -36.85 | -16.46 | -10.12 | -11.71 |
| Diluted Average Shares | 18.14 | 18.84 | 18.77 | 18.56 |
| Basic Average Shares | 18.14 | 18.84 | 18.77 | 18.56 |
| Diluted NI Availto Com Stockholders | -37.52 | -16.32 | -9.13 | -11.37 |
| Net Income Including Noncontrolling Interests | -37.52 | -16.32 | -9.13 | -11.37 |
| Net Income Continuous Operations | -37.52 | -16.32 | -9.13 | -11.37 |
| Other Income Expense | 11.36 | 38.66 | 42.58 | 37.39 |
| Other Non Operating Income Expenses | 0.26 | 0.27 | 0.23 | 0.07 |
| Special Income Charges | 11.10 | 38.39 | 42.34 | 37.32 |
| Gain On Sale Of Ppe | 11.10 | 38.39 | 42.34 | 41.09 |
| Impairment Of Capital Assets | 0 | 0 | 0 | 0 |
| Restructuring And Mergern Acquisition | 0 | 0 | 0 | 3.77 |
| Earnings From Equity Interest | 0 | 0 | 0 | 0 |
| Net Non Operating Interest Income Expense | 0.06 | 1.14 | 2.37 | 2.16 |
| Interest Income Non Operating | 0.06 | 1.14 | 2.37 | 2.16 |
| Depreciation Amortization Depletion Income Statement | 1.45 | 1.42 | 0.84 | 0.55 |
| Depreciation And Amortization In Income Statement | 1.45 | 1.42 | 0.84 | 0.55 |
| Selling And Marketing Expense | 4.46 | 5.73 | 5.69 | 6.11 |
| General And Administrative Expense | 39.52 | 45.18 | 44.42 | 42.67 |
| Other Gand A | 39.52 | 45.18 | 44.42 | 42.67 |
| Operating Revenue | 1.08 | 1.92 | 4.19 | 6.03 |
